Table 12. Effect of treatment on antibody titers against SRBC, IgG, and IgM at day 28 and 42.
| Treatments | SRBC (28 days) |
IgG (28 days) |
IgM (28 days) |
SRBC (42 days) |
IgG (42 days) |
IgM (42 days) |
|---|---|---|---|---|---|---|
| Control | 2.3 | 1.0b | 1.3 | 4.3 | 2.7 | 1.7 |
| Flavophospholipol | 4.0 | 1.3a | 1.7 | 5.0 | 3.0 | 1.7 |
| Probiotics | 4.7 | 2.3a | 2.7 | 6.0 | 3.3 | 2.7 |
| 0.25% HP | 2.7 | 1.7a | 1.0 | 4.7 | 3.3 | 1.7 |
| 0.50% HP | 4.0 | 1.3a | 1.7 | 5.0 | 3.3 | 1.3 |
| 0.75% HP | 4.7 | 2.3a | 2.7 | 6.0 | 3.7 | 2.3 |
| SEM | 1.00 | 0.71 | 0.53 | 0.73 | 0.72 | 0.33 |
| P-value | 0.586 | 0.024 | 0.265 | 0.531 | 0.964 | 0.194 |
Means with different subscripts in the same column differ significantly (P<0.05); SEM: Standard error of means.